Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2017 Aug 01;288:2540-2552. doi: 10.1681/ASN.2016101057.
Show Gene links
Show Anatomy links
Clinical and Genetic Spectrum of Bartter Syndrome Type 3.
Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R.
???displayArticle.abstract???
Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (CLCNKB), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule. To study phenotype/genotype correlations, we performed genetic analyses by direct sequencing and multiplex ligation-dependent probe amplification and retrospectively analyzed medical charts for 115 patients with CLCNKB mutations. Functional analyses were performed in Xenopus laevis oocytes for eight missense and two nonsense mutations. We detected 60 mutations, including 27 previously unreported mutations. Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood). Nine of the ten mutations expressed in vitro decreased or abolished chloride conductance. Severe (large deletions, frameshift, nonsense, and essential splicing) and missense mutations resulting in poor residual conductance were associated with younger age at diagnosis. Electrolyte supplements and indomethacin were used frequently to induce catch-up growth, with few adverse effects. After a median follow-up of 8 (range, 1-41) years in 77 patients, chronic renal failure was detected in 19 patients (25%): one required hemodialysis and four underwent renal transplant. In summary, we report a genotype/phenotype correlation for Bartter syndrome type 3: complete loss-of-function mutations associated with younger age at diagnosis, and CKD was observed in all phenotypes.
Akil,
A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.
2010, Pubmed
Akil,
A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.
2010,
Pubmed Andrini,
CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels.
2014,
Pubmed Andrini,
ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.
2015,
Pubmed Bacchetta,
The consequences of chronic kidney disease on bone metabolism and growth in children.
2012,
Pubmed BARTTER,
Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.
1962,
Pubmed Bettinelli,
Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome.
2007,
Pubmed Birkenhäger,
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure.
2001,
Pubmed Blethen,
Reversal of Bartter's syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis.
1985,
Pubmed Boer,
Bartter's syndrome with impairment of growth hormone secretion.
1992,
Pubmed Brochard,
Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.
2009,
Pubmed Bulucu,
Association of Gitelman's syndrome and focal glomerulosclerosis.
1998,
Pubmed Buyukcelik,
Bartter syndrome and growth hormone deficiency: three cases.
2012,
Pubmed Cho,
Translational read-through of a nonsense mutation causing Bartter syndrome.
2013,
Pubmed Flyvbjerg,
Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I.
1991,
Pubmed García Castaño,
Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm.
2013,
Pubmed Grill,
Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene.
2016,
Pubmed Hanevold,
C1q nephropathy in association with Gitelman syndrome: a case report.
2006,
Pubmed Hennings,
The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.
2017,
Pubmed Hochberg,
Growth hormone (GH) receptor and GH-binding protein deficiency in the growth failure of potassium-depleted rats.
1995,
Pubmed Houdayer,
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF.
2004,
Pubmed Imbrici,
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.
2016,
Pubmed Jeck,
The diuretic- and Bartter-like salt-losing tubulopathies.
2000,
Pubmed Jeck,
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype.
2000,
Pubmed Keck,
Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression.
2013,
Pubmed
,
Xenbase Kobayashi,
Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear.
2002,
Pubmed Konrad,
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.
2000,
Pubmed Lan,
TGF-β/Smad signaling in kidney disease.
2012,
Pubmed Lee,
Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis.
2011,
Pubmed Nozu,
Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.
2007,
Pubmed Peters,
Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.
2002,
Pubmed Rodríguez-Soriano,
Bartter and related syndromes: the puzzle is almost solved.
1998,
Pubmed Schlingmann,
Salt wasting and deafness resulting from mutations in two chloride channels.
2004,
Pubmed
,
Xenbase Seyberth,
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
2011,
Pubmed Simon,
Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
1996,
Pubmed Simon,
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.
1997,
Pubmed Simon,
Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.
1996,
Pubmed Simon,
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.
1996,
Pubmed Stölting,
Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking.
2015,
Pubmed Teulon,
Exploration of the basolateral chloride channels in the renal tubule using.
2005,
Pubmed Vargas-Poussou,
Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.
2002,
Pubmed Vargas-Poussou,
Spectrum of mutations in Gitelman syndrome.
2011,
Pubmed Watanabe,
Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
2002,
Pubmed Yokoyama,
[Endocrinological analysis before and after living-related renal transplantation in a patient of Bartter's syndrome].
1995,
Pubmed Zelikovic,
A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.
2003,
Pubmed
